Eli Lilly and Company (LLY) $781.983.91(0.50%) Bid: 775.00 x 100Ask: 786.69 x 100 January 3, 2025 4:00 PMESTVolume: 1,799,992 After Hours: $781.00-0.98(-0.13%)January 3, 2025 5:35 PMESTVolume: 248,079 USDNew York Stock ExchangeDelayed PriceMarket Closed Earnings High Target Price...
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030 Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and currently trading at $785.99. The company has been around since 1876 and the... Joel South ...
Eli Lilly的财务健康状况根据公司超100多个因子相比发达市场中医疗保健行业内其他公司的排名确定。 12345 表现良好▼ 3 现金流稳健度 3 成长稳健度 3 价格动能 4 盈利能力稳健度 1 相对价值 Eli Lilly and Company的财务模型 模型库 10年EBITDA现金流贴现退出法查看 更新于21小时前天前 10年收入现金流贴现退出法...
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know Jan. 3, 2025 at 9:00 a.m. ETon Zacks.com Pfizer Rises 5.6% in a Month: How Should You Play the Stock? Jan. 3, 2025 at 8:53 a.m. ETon Zacks.com ...
Eli Lilly and Company is a medicine company. The Company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Mounjaro, Trulicity and Zepbound. Its oncology products includ...
Evolution of Eli Lilly and Company market cap in the past 5 years Market capitalizations are calculated from the opening stock price at the beginning of each month. Market Cap History of Eli Lilly and Company Detailed Description Eli Lilly and Company discovers, develops, and markets human pharmac...
Eli Lilly and Company - SNSE:LLY Multiples Valuation: Price / Book 分享保存 股票价格 760.60 USD 公允价值 566.55 USD 看涨 -25.5% Price / Book Multiple Fair Value Benchmark Editor Select Price / Book Ratio Benchmark Companies ZTS MRK PFE SUPN AMPH LLY NYSE:ZTS NYSE:MRK NYSE:PFE Nasdaq...
A high-level overview of Eli Lilly and Company (LLY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Eli Lilly and Company LLY boasts a solid portfolio of core drugs in diabetes, autoimmune diseases and cancer. Its revenue growth is being driven by higher demand for drugs like Jardiance, Verzenio, Taltz and others. Lilly has late
business Lilly Company Profile LLY - Stock Indices S&P 500 Russell 1000 Russell 3000 LLY Stock Price - 1 Year Price Evolution & Moving Averages 1 Year Return ▲+26.42% file_download Daily closing prices, with moving averages and volumes - United States dollar (USD) Moving averages: ...